| 标题 |
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:eClinicalMedicine 作者:Xuefeng Fang; Ning Zhu; Chenhan Zhong; Liuhong Wang; Jun Li; et al 出版日期:2023-08-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)